Enanta Pharmaceuticals, Inc. (ENTA)

NASDAQ: ENTA · Real-Time Price · USD

6.99

-0.13 (-1.83%)

At close: Aug 7, 2025, 4:00 PM

6.88

-0.11 (-1.57%)

Pre-market: Aug 8, 2025, 4:26 AM EDT

Enanta Pharmaceuticals Ratios and Metrics

Market cap in millions USD. Fiscal year is October - September.

Millions USD. Fiscal year is Oct - Sep.

Fiscal Year	Current	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020	2016 - 2020
Period Ending	Aug '25 Aug 7, 2025	Sep '24 Sep 30, 2024	Sep '23 Sep 30, 2023	Sep '22 Sep 30, 2022	Sep '21 Sep 30, 2021	Sep '20 Sep 30, 2020	2016 - 2020
Market Capitalization	149	220	235	1,075	1,148	919	Upgrade
Market Cap Growth	-68.12%	-6.67%	-78.12%	-6.39%	24.98%	-22.29%	Upgrade
Enterprise Value	172	173	73	809	784	494	Upgrade
Last Close Price	6.99	10.36	11.17	51.87	56.81	45.78	Upgrade
PS Ratio	2.30	3.25	2.97	12.48	11.83	7.50	Upgrade
PB Ratio	1.60	1.70	1.09	3.35	2.88	2.02	Upgrade
P/TBV Ratio	1.60	1.70	1.09	3.35	2.88	2.02	Upgrade
P/FCF Ratio	-	-	-	-	-	162.84	Upgrade
P/OCF Ratio	-	-	-	-	-	129.64	Upgrade
EV/Sales Ratio	2.67	2.56	0.93	9.39	8.08	4.03	Upgrade
EV/FCF Ratio	-	-	-	-	-	87.53	Upgrade
Debt / Equity Ratio	2.31	1.76	1.03	0.08	0.02	0.02	Upgrade
Debt / FCF Ratio	-	-	-	-	-	1.70	Upgrade
Asset Turnover	0.18	0.16	0.19	0.21	0.21	0.25	Upgrade
Quick Ratio	5.09	4.99	6.52	10.00	8.43	17.52	Upgrade
Current Ratio	5.29	5.21	6.73	10.45	8.82	18.08	Upgrade
Return on Equity (ROE)	-74.27%	-67.16%	-49.74%	-33.78%	-18.48%	-7.88%	Upgrade
Return on Assets (ROA)	-17.33%	-18.13%	-20.47%	-19.01%	-14.81%	-5.33%	Upgrade
Return on Capital (ROIC)	-18.09%	-19.16%	-21.79%	-20.52%	-15.72%	-5.60%	Upgrade
Earnings Yield	-64.53%	-52.86%	-56.90%	-11.33%	-6.88%	-3.94%	Upgrade
FCF Yield	-55.04%	-44.06%	-47.71%	-8.08%	-6.16%	0.61%	Upgrade
Buyback Yield / Dilution	-0.70%	-0.90%	-1.78%	-2.14%	-1.16%	4.90%	Upgrade

Updated Feb 12, 2025. Source: S&P Global Market Intelligence. Standard template. Financial Sources.

SEC Filings: 10-K · 10-Q